These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 38378607)

  • 1. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants.
    Hong H; Hong L; Luo X; Zeng Q; Li K; Wang S; Jiaerken Y; Zhang R; Yu X; Zhang Y; Lei C; Liu Z; Chen Y; Huang P; Zhang M;
    Alzheimers Res Ther; 2024 Feb; 16(1):43. PubMed ID: 38378607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
    Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
    Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study.
    Tian Y; Cai X; Zhou Y; Jin A; Wang S; Yang Y; Mei L; Jing J; Li S; Meng X; Wei T; Liu T; Wang Y; Pan Y; Wang Y
    Stroke Vasc Neurol; 2023 Oct; 8(5):413-423. PubMed ID: 37045543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
    Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
    Kim M; Song YS; Han K; Bae YJ; Han JW; Kim KW
    J Alzheimers Dis; 2024; 99(1):279-290. PubMed ID: 38669532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glymphatic Dysfunction Mediates the Influence of White Matter Hyperintensities on Episodic Memory in Cerebral Small Vessel Disease.
    Ke Z; Mo Y; Li J; Yang D; Huang L; Yang Z; Qin R; Mao C; Lv W; Huang Y; Hu Z; Zhang B; Xu Y
    Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
    Kamagata K; Andica C; Takabayashi K; Saito Y; Taoka T; Nozaki H; Kikuta J; Fujita S; Hagiwara A; Kamiya K; Wada A; Akashi T; Sano K; Nishizawa M; Hori M; Naganawa S; Aoki S;
    Neurology; 2022 Dec; 99(24):e2648-e2660. PubMed ID: 36123122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling connections between venous disruption and cerebral small vessel disease using diffusion tensor image analysis along perivascular space (DTI-ALPS): A 7-T MRI study.
    Zhang X; Pei X; Shi Y; Yang Y; Bai X; Chen T; Zhao Y; Yang Q; Ye J; Leng X; Yang Q; Bai R; Wang Y; Sui B
    Int J Stroke; 2024 Nov; ():17474930241293966. PubMed ID: 39402900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
    Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
    Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of Perivascular Space Markers With Incident Dementia in Cerebral Small Vessel Disease.
    Hong H; Tozer DJ; Markus HS
    Stroke; 2024 Apr; 55(4):1032-1040. PubMed ID: 38465597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/MRI multimodality imaging to evaluate changes in glymphatic system function and biomarkers of Alzheimer's disease.
    Okazawa H; Nogami M; Ishida S; Makino A; Mori T; Kiyono Y; Ikawa M
    Sci Rep; 2024 May; 14(1):12310. PubMed ID: 38811627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of glymphatic system activity by diffusion tensor image analysis along the perivascular space (DTI-ALPS) in dementia patients.
    Liang T; Chang F; Huang Z; Peng D; Zhou X; Liu W
    Br J Radiol; 2023 Jun; 96(1146):20220315. PubMed ID: 37066824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glymphatic dysfunction mediates the influence of choroid plexus enlargement on information processing speed in patients with white matter hyperintensities.
    Xu Y; Wang M; Li X; Lu T; Wang Y; Zhang X; Wang Z; Yan F
    Cereb Cortex; 2024 Jun; 34(6):. PubMed ID: 38912605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships Between the Deposition of Amyloid-β and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.
    Ota M; Sato N; Nakaya M; Shigemoto Y; Kimura Y; Chiba E; Yokoi Y; Tsukamoto T; Matsuda H
    J Alzheimers Dis; 2022; 90(1):295-303. PubMed ID: 36120782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting-state fMRI network efficiency as a mediator in the relationship between the glymphatic system and cognitive function in obstructive sleep apnea hypopnea syndrome: Insights from a DTI-ALPS investigation.
    Xiong Z; Bai M; Wang Z; Wang R; Tian C; Wang L; Nie L; Zeng X
    Sleep Med; 2024 Jul; 119():250-257. PubMed ID: 38704873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid Positivity in the Alzheimer/Subcortical-Vascular Spectrum.
    Kang SH; Kim ME; Jang H; Kwon H; Lee H; Kim HJ; Seo SW; Na DL
    Neurology; 2021 Apr; 96(17):e2201-e2211. PubMed ID: 33722997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perivascular Spaces, Diffusivity Along Perivascular Spaces, and Free Water in Cerebral Small Vessel Disease.
    Li H; Jacob MA; Cai M; Kessels RPC; Norris DG; Duering M; De Leeuw FE; Tuladhar AM
    Neurology; 2024 May; 102(9):e209306. PubMed ID: 38626373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
    Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
    Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glymphatic function from diffusion-tensor MRI to predict conversion from mild cognitive impairment to dementia in Parkinson's disease.
    Pang H; Wang J; Yu Z; Yu H; Li X; Bu S; Zhao M; Jiang Y; Liu Y; Fan G
    J Neurol; 2024 Aug; 271(8):5598-5609. PubMed ID: 38913186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
    Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
    Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.